Analyst Recommendations

5.45 -0.05(-0.91%)09/16/2024
Verve Therapeutics Inc (VERV)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy4
Outperform2

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades